Lesson plan

BMS-470539

BMS-470539 is a small-molecule experimental drug which acts as a potent and highly selective full agonist of the MC 1 receptor. It was discovered in 2003 as part of an effort to understand the role of the MC 1 receptor in immunomodulation, and has since been used in scientific research to determine its role in inflammatory processes. The compound was designed with the intention of mimicking the central His-Phe-Arg-Trp pharmacophore of the melanocortins, and this proved to be successful based on its favorable pharmacodynamic profile.

Back to article

Article summary

BMS-470539 is a small-molecule experimental drug which acts as a potent and highly selective full agonist of the MC 1 receptor. It was discovered in 2003 as part of an effort to understand the role of the MC 1 receptor in immunomodulation, and has since been used in scientific research to determine its role in inflammatory processes. The compound was designed with the intention of mimicking the central His-Phe-Arg-Trp pharmacophore of the melanocortins, and this proved to be successful based on its favorable pharmacodynamic profile.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.